GLOBALT Investments’s Vertex Pharmaceuticals VRTX Stock Holding History

GLOBALT Investments’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.13M	Buy	4,773 +30	+0.6%	+$14K	0.08%	113
2025 Q4	$2.15M	Sell	4,743 -29	-0.6%	-$12.5K	0.08%	111
2025 Q3	$1.87M	Sell	4,772 -2,513	-34%	-$1.05M	0.07%	116
2025 Q2	$3.24M	Sell	7,285 -410	-5%	-$189K	0.12%	96
2025 Q1	$3.73M	Sell	7,695 -293	-4%	-$137K	0.15%	89
2024 Q4	$3.22M	Buy	7,988 +63	+0.8%	+$29.2K	0.12%	96
2024 Q3	$3.69M	Sell	7,925 -161	-2%	-$77.3K	0.14%	87
2024 Q2	$3.79M	Sell	8,086 -152	-2%	-$66K	0.15%	81
2024 Q1	$3.44M	Sell	8,238 -301	-4%	-$127K	0.14%	89
2023 Q4	$3.47M	Buy	+8,539	New	+$3.15M	0.14%	89

Other funds holding VRTX

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

GLOBALT Investments's VRTX Position: Q1 2026 in Review

GLOBALT Investments increased its Vertex Pharmaceuticals (VRTX) stake by 0.63% in Q1 2026, buying an estimated $14K and bringing the position to 4,773 shares worth $2.13M. The position accounts for 0.08% of the portfolio, ranked #113.

GLOBALT Investments first reported a position in VRTX in Q4 2023 and has held it in 10 quarters since. The position peaked at $3.79M in Q2 2024. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

GLOBALT Investments held 4,773 shares of Vertex Pharmaceuticals worth $2.13M as of Q1 2026.
GLOBALT Investments bought 30 Vertex Pharmaceuticals shares in Q1 2026, an estimated $14K.
Vertex Pharmaceuticals made up 0.08% of GLOBALT Investments's portfolio in Q1 2026, its #113 holding.
GLOBALT Investments first reported a position in Vertex Pharmaceuticals in Q4 2023 and has held it in 10 quarters since.
GLOBALT Investments's Vertex Pharmaceuticals position peaked at $3.79M in Q2 2024.
1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on GLOBALT Investments's 13F filing for Q1 2026, filed 15 May 2026.